Luminescent TiO nanoparticles synthesized from Mollugo Oppositifolia and Trianthema Portulacastrum for dye degradation, antimicrobial and antioxidant properties.

In modern times, nanoparticles have materialized as indispensable things in contemporary medicine, with a variety of uses in clinical, drug and gene conveyance. In the present study, TiO nanoparticles (NPs) prepared from the leaf extracts of Mollugooppositifolia and Trianthema portulacastrum were compared with the chemical TiO-NPs for antibacterial and antioxidant activities and environment-friendly nature through various tools like the UV-visible, X-ray diffraction with the aid of other analytical techniques like HR-TEM, Fourier transform infrared (FT-IR) and photoluminescence spectroscopic techniques. The morphology of green TiO-NPs is found to be spherical, which is supported by HR-TEM images.

Chromene Carbohydrazide- Schiff Base as a Highly Selective Turn-Off Fluorescence Chemosensor for In Ion and its Application.

A new 7-(diethylamino)-2-oxo-2 H-chromene-3-carbohydrazide design to synthesize a simple Schiff-base condition. The synthesized molecules' (probe L) photophysical properties were investigated in various solvent systems and solvent-poor-solvent assays. Probe L exhibits the absorbance band at 440 nm and the emission band at 488 nm in DMSO: HO (7:3, v/v).

Biomass derived nitrogen functionalized carbon nanodots for nanomolar determination of levofloxacin in pharmaceutical and water samples.

Binder-free and efficient electrochemical sensing of levofloxacin (LF) was successfully developed based on the nitrogen-doped carbon nanodots (NCNDs). The NCNDs were synthesized by hydrothermal carbonation (180°C for 12 h), and the heteroatom was embedded in aqueous solution of ammonia (NH). Spectral and microscopic characteristization techniques were used to analyze the topological, crystallinity, and chemical binding behavior of synthesized biomass functional material.

Heterozygous expression of the Alzheimer's disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses.

Background: A rare coding variant, P522R, in the phospholipase C gamma 2 (PLCG2) gene has been identified as protective against late-onset Alzheimer's disease (AD), but the mechanism is unknown. PLCG2 is exclusively expressed in microglia within the central nervous system, and altered microglial function has been implicated in the progression of AD.

Methods: Healthy control hiPSCs were CRISPR edited to generate cells heterozygous and homozygous for the PLCG2 variant.